Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 113, Issue 5b, Pages E98-E105
Publisher
Wiley
Online
2013-07-19
DOI
10.1111/bju.12367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer in Denmark 1978–2009 — trends in incidence and mortality
- (2012) Malene Outzen et al. ACTA ONCOLOGICA
- Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS)
- (2012) Albert El Hajj et al. BJU INTERNATIONAL
- Active surveillance
- (2012) Laurence Klotz CURRENT OPINION IN UROLOGY
- Active surveillance in prostate cancer
- (2012) Kathryn Lees et al. CURRENT OPINION IN UROLOGY
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
- (2012) Meelan Bul et al. EUROPEAN UROLOGY
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study
- (2012) Jean-Baptiste Beauval et al. UROLOGY
- Prostate cancer epidemiology in the United States
- (2012) Otis W. Brawley WORLD JOURNAL OF UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
- (2010) M. Frank O'Brien et al. INTERNATIONAL JOURNAL OF CANCER
- Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program
- (2010) Ashley E. Ross et al. JOURNAL OF CLINICAL ONCOLOGY
- Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications
- (2009) Patrick J. Bastian et al. EUROPEAN UROLOGY
- Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy
- (2009) Matthew Frank O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
- (2009) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
- (2008) Philip M. Arlen et al. JOURNAL OF UROLOGY
- PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer
- (2008) David Robinson et al. UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started